GT
APSG.WS

Glenmede Trust’s Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer APSG.WS Stock Holding History

Glenmede Trust’s Portfolio APSG.WS Stock Details APSG.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,974
Closed -$22K – 1397
2021
Q3 		$22K Buy
+27,974
New +$28.9K ﹤0.01% 1243

Other funds holding APSG.WS

AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Glenmede Trust's APSG.WS Position: Q4 2021 in Review

Glenmede Trust sold out of Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer (APSG.WS) in Q4 2021, closing a stake of 27,974 shares — an estimated $22K sold.

Glenmede Trust first reported a position in APSG.WS in Q3 2021 and held it in 1 quarter. The position peaked at $22K in Q3 2021. 65 funds tracked by Wall St. Rank hold APSG.WS as of Q4 2021.

  • Glenmede Trust reported no remaining Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position as of Q4 2021 after selling out during the quarter.
  • Glenmede Trust sold 27,974 Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer shares in Q4 2021, an estimated $22K.
  • Glenmede Trust first reported a position in Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer in Q3 2021 and held it in 1 quarter.
  • Glenmede Trust's Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position peaked at $22K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer as of Q4 2021.

Based on Glenmede Trust's 13F filing for Q4 2021, filed 15 Feb 2022.